Trial Profile
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2016
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- Acronyms S-COT
- 10 Jun 2016 Status changed from active, no longer recruiting to completed.
- 09 Jun 2016 Results published in the Investigational New Drugs
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology